Page 3 - Ted Steiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) Virtual event scheduled for Thursday, April 29 at 1 pm Eastern Time TORONTO, ON / ACCESSWIRE / April 22, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that it will host a key opinion leader (KOL) webinar on EB05, the company's lead asset for the treatment of Acute Respiratory Distress Syndrome (ARDS), on Thursday, April 29, 2021 at 1:00 pm Eastern Time. The webinar will feature a presentation by KOL Ted Steiner, MD, University of British Columbia, who will discuss the current treatm...

COVID-19 cases continue to escalate worldwide The original announcement by the National Research Council of Canada is available at bit.ly/2JRa4fQ. BOLD-100 is a first-in-class ruthenium-based small molecule drug which selectively inhibits stress-induced upregulation of the chaperone protein GRP78. Currently, the investigational treatment is in a Phase 1b clinical trial in gastrointestinal cancer. In cancer, GRP78 plays a critical role in resistance, survival and proliferation, whereas in viral infections, GRP78 plays a critical role in host recognition, viral entry and viral replication. Prec...